These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1461177)

  • 1. The role of lipid peroxidation in McArdle's disease: applications for treatment of other myopathies.
    Russo PJ; Phillips JW; Seidler NW
    Med Hypotheses; 1992 Oct; 39(2):147-51. PubMed ID: 1461177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
    Lewis SF; Haller RG
    J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myophosphorylase deficiency impairs muscle oxidative metabolism.
    Haller RG; Lewis SF; Cook JD; Blomqvist CG
    Ann Neurol; 1985 Feb; 17(2):196-9. PubMed ID: 3856415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
    Quinlivan R; Beynon RJ
    Cochrane Database Syst Rev; 2004; (3):CD003458. PubMed ID: 15266486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
    Sahlin K; Areskog NH; Haller RG; Henriksson KG; Jorfeldt L; Lewis SF
    J Appl Physiol (1985); 1990 Oct; 69(4):1231-5. PubMed ID: 2262440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
    Beynon RJ; Bartram C; Hopkins P; Toescu V; Gibson H; Phoenix J; Edwards RH
    Muscle Nerve Suppl; 1995; 3():S18-22. PubMed ID: 7603521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-parametric protocol to study exercise intolerance in McArdle's disease.
    Ricci G; Bertolucci F; Logerfo A; Simoncini C; Papi R; Franzoni F; Dell'Osso G; Servadio A; Masoni MC; Siciliano G
    Acta Myol; 2015 Dec; 34(2-3):120-125. PubMed ID: 27199539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased muscular beta-hydroxyacyl CoA dehydrogenase with McArdle's disease.
    Turk WR; Heller SL; Norris BJ; Nemeth PM
    Muscle Nerve; 1990 Jul; 13(7):607-12. PubMed ID: 2388659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
    Sahlin K; Jorfeldt L; Henriksson KG; Lewis SF; Haller RG
    Clin Sci (Lond); 1995 Jun; 88(6):687-93. PubMed ID: 7634753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies.
    Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M
    Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [McArdle's disease without typical symptoms].
    Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
    Jehenson P; Leroy-Willig A; de Kerviler E; Duboc D; Syrota A
    AJR Am J Roentgenol; 1993 Aug; 161(2):347-51. PubMed ID: 8333376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second wind phenomenon in McArdle's disease.
    Braakhekke JP; de Bruin MI; Stegeman DF; Wevers RA; Binkhorst RA; Joosten EM
    Brain; 1986 Dec; 109 ( Pt 6)():1087-101. PubMed ID: 3466659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
    Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucose metabolism during muscular exercise in McArdle's disease].
    Krzentowski G; Pallikarakis N; Pirnay F
    Acta Clin Belg; 1979; 34(3):151-7. PubMed ID: 292291
    [No Abstract]   [Full Text] [Related]  

  • 18. Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising.
    Perez M; Martin MA; Rubio JC; Maté-Muñoz JL; Gómez-Gallego F; Foster C; Andreu AL; Arenas J; Lucia A; Fleck SJ
    Br J Sports Med; 2006 Aug; 40(8):725-6; discussion 726. PubMed ID: 16864568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low muscle levels of pyridoxine in McArdle's syndrome.
    Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
    Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [McArdle's disease. Apropos of a case].
    Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
    Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.